Identifying the Role of Flow Mediated Dilatation Assessment in Acute Coronary Syndromes - Evaluation of the Cor-IS Technology (the FLARE-ACS Trial)

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices. The novel Cor-IS technology will also be evaluated.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Age \> 18 years

• Patients hospitalized due to acute coronary syndrome (STEMI, NSTEMI)

• Capability of providing written informed consent

• Patients able to comply with the follow-up schedule of the study

Locations
Other Locations
Greece
Ippokratio General Hospital
RECRUITING
Thessaloniki
Contact Information
Primary
Christodoulos E. Papadopoulos, PhD
chrpapado@gmail.com
2313312343
Backup
Georgios Zormpas, MD
sparky.zorb@gmail.com
2313312343
Time Frame
Start Date: 2024-06-01
Estimated Completion Date: 2026-11-01
Participants
Target number of participants: 100
Treatments
Observation group
Patients hospitalized due to acute coronary syndromes (STEMI, NSTEMI)
Related Therapeutic Areas
Sponsors
Leads: Aristotle University Of Thessaloniki

This content was sourced from clinicaltrials.gov